Background: The SCIM-SR, a self-report instrument, offers a patient-centered perspective. To ensure its clinical and scientific utility in Thailand, it is essential to establish the reliability of a translated and culturally adapted Thai version. Objectives: To investigate the reliability of the SCIM-SR-Thai in chronic persons with SCI using a test-retest approach after 7 days. Materials and methods: Thai adults aged 20-80 years with chronic SCI for at least 1 year were recruited. Participants filled out the SCIM-SR-Thai in-office once and were given a second copy to be completed at 7 days at their leisure. Participants were instructed to mail the questionnaire back within 14 days or would be considered a drop-out. Results: A total of 59 participants completed the study. The majority were male (62.7%). The mean (SD) age was 48.5 (15.4) with median (IQR) time since SCI of 12 (6-21) years. Most of the participants were diagnosed with T1-S3 AIS A, B, and C 38/59 (64.4%). The SCIM-SR-Thai demonstrated excellent internal consistency and test-retest reliability (Cronbach’s alpha 0.99, ICC=0.97; 95% CI=0.95-0.98). Analyses of individual subscales yielded similar results. Conclusion: SCIM-SR-Thai demonstrates good reliability and internal consistency. The authors encourage adoption of this questionnaire as a standardized tool in clinical practice to assess functional independence in people with SCI.

M5C-methylated EDIL3 attenuates spinal cord ischemia-reperfusion injury by suppressing neutrophil extracellular trap formation.

Autophagy activation by the Becn1F121A mutation reprograms neuroinflammation and promotes neurological recovery after spinal cord injury.

Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy.

Neurosarcoidosis masquerading as recurrent tumefactive demyelinating-appearing brain lesions: An 8-year diagnostic odyssey.

Development of a treatment planning protocol for the multi-centre reirradiation CURE Lung trial.

Contribution of S1pr1 -featured astrocyte subpopulation to cisplatin-induced neuropathic pain in male mice.

5-methoxyflavone promotes functional recovery of spinal cord injury by competitively inhibiting adenosine A1 receptor-induced neuroinflammation.

A filum terminale arteriovenous fistula fed by the left L1 artery of adamkiewicz: a case report and updated systematic review of 71 cases.

Association and mechanism of Ligusticum chuanxiong alleviating itch: A combination of experimental and network pharmacology study.

Anatomy of the Locus Coeruleus Defined by a Multimodal Approach.

Bone marrow mesenchymal stem cell-derived exosomes alleviate neuropathic pain after spinal cord injury by inhibiting the TLR4/MyD88/NF-κB pathway.

Limited effects of the REV-ERB agonist SR9009 after mouse spinal cord contusion: Reduced acute pathology with unaffected functional recovery and chronic white matter loss.

Fabrication and evaluation of Edaravone-loaded chitosan/polyvinyl alcohol electrospun nanofibers scaffold for spinal cord injury repair.

Targeting kynurenine pathway and A1 /A2 astrocytes polarization in experimentally induced fibromyalgia: Modulatory role of apigenin on kynurenine/ aryl hydrocarbon receptor signaling.

Nerve and tendon transfer surgery has restored upper extremity function in cervical spinal cord injury but is not universally accessible to all eligible individuals. The purpose of this exploratory qualitative study was to understand the healthcare provider factors that are associated with access to nerve transfer surgery for people with spinal cord injury. Semistructured interviews explored healthcare provider knowledge and practices regarding nerve and tendon transfer surgery to improve upper extremity function in cervical spinal cord injury. An inductive, iterative, constant comparative process involving descriptive and interpretive data analyses was used to identify themes, guided by the Consolidated Framework for Implementation Research. Interviews were conducted with healthcare providers ( n = 10 upper extremity surgeons, n = 10 spinal cord injury physiatrists/hospitalists, n = 6 occupational therapists, n = 6 physical therapists). The following nine themes were identified as barriers to accessing care: (1) lack of awareness; (2) lack of sufficient knowledge; (3) lack of buy-in as a priority; (4) lack of collaboration; (5) misperceptions; (6) lack of resources; (7) lack of evidence; (8) lack of ownership among rehabilitation specialists; and (9) hesitancy. This study identified barriers limiting equitable access to nerve transfer surgery. These barriers highlight the need for a multimodal multidisciplinary approach to address individual-, provider-, and system-level barriers.

Fujian tablet regulates the Foxo3a/GPX4 axis to promote remyelination and improve motor function in ischemic stroke.

Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study.

Vulnerable Thrombus as a Cause of Spinal Cord Ischemia After Thoracic Endovascular Aortic Repair: Tokai Multicenter Study.

Transcutaneous auricular vagus nerve stimulation promotes post-spinal cord injury remyelination via α7nAChR-mediated activation of oligodendrocyte precursor cells.